EFFECTS OF NABUMETONE AND ITS ACTIVE METABOLITE, 6-METHOXY-2-NAPHTHYLACETIC ACID (6-MNA), ON THROMBOXANE BIOSYNTHESIS IN-VIVO AND IN-VITRO

被引：0
|
作者：
PATRIGNANI, P [1 ]
CIPOLLONE, F [1 ]
DISIPIO, M [1 ]
DIFEBBO, C [1 ]
PORRECA, E [1 ]
GANCI, A [1 ]
DELBIANCO, A [1 ]
CUCCURULLO, F [1 ]
PATRONO, C [1 ]
机构：
[1] UNIV CHIETI,G DANNUZIO SCH MED,DEPT MED PATHOPHYSIOL,I-66013 CHIETI,ITALY
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1994年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P76 / P76
页数：1
相关论文
共 35 条
  • [1] ANTIINFLAMMATORY AND GASTROINTESTINAL EFFECTS OF NABUMETONE OR ITS ACTIVE METABOLITE, 6MNA (6-METHOXY-2-NAPHTHYLACETIC ACID) - COMPARISON WITH INDOMETHACIN
    MELARANGE, R
    GENTRY, C
    OCONNELL, C
    BLOWER, PR
    NEIL, C
    KELVIN, AS
    TOSELAND, CDN
    AGENTS AND ACTIONS, 1992, : C82 - C83
  • [2] POLYMORPHONUCLEAR LEUKOCYTES ACTIVATION - IN-VITRO MODULATION BY 6-METHOXY-2-NAPHTHYLACETIC ACID, THE MAJOR ACTIVE METABOLITE OF NABUMETONE
    ALLEGREZZAGIULIETTI, A
    SERRETTI, R
    PERONI, M
    CERVINI, C
    PHARMACOLOGICAL RESEARCH, 1993, 28 (02) : 163 - 173
  • [3] ANTIINFLAMMATORY AND GASTROINTESTINAL EFFECTS OF NABUMETONE OR ITS ACTIVE METABOLITE, 6-METHOXY-2-NAPHTHYLACETIC ACID (6MNA) - COMPARATIVE-STUDIES WITH INDOMETHACIN
    MELARANGE, R
    GENTRY, C
    OCONNELL, C
    BLOWER, PR
    NEIL, C
    KELVIN, AS
    TOSELAND, CDN
    DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (12) : 1847 - 1852
  • [4] Disposition and excretion of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone in horses
    Soma, LR
    Uboh, CE
    Rudy, JA
    Smith, MS
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1996, 57 (04) : 517 - 521
  • [5] A metabolic pathway for the prodrug nabumetone to the pharmacologically active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA) by non-cytochrome P450 enzymes
    Matsumoto, Kaori
    Hasegawa, Tetsuya
    Ohara, Kosuke
    Takei, Chihiro
    Kamei, Tomoyo
    Koyanagi, Junichi
    Takahashi, Tamiko
    Akimoto, Masayuki
    XENOBIOTICA, 2020, 50 (07) : 783 - 792
  • [6] Potential of Piperazinylalkylester Prodrugs of 6-Methoxy-2-Naphthylacetic Acid (6-MNA) for Percutaneous Drug Delivery
    Vijay Pawar
    Rushabh Thosani
    Ashish Kanhed
    Rajani Giridhar
    Mange Ram Yadav
    AAPS PharmSciTech, 2015, 16 : 518 - 527
  • [7] The in vitro effects of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone, on rat gastric mucosal eicosanoid synthesis and metabolism
    Melarange, R
    Spangler, R
    Hoult, JRS
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1996, 55 (03): : 195 - 200
  • [8] INVITRO EFFECTS OF 6-METHOXY-2-NAPHTHYLACETIC ACID, THE MAJOR ACTIVE METABOLITE OF NABUMETONE, ON POLYMORPHONUCLEAR LEUKOCYTE FUNCTIONS
    ALLEGREZZAGIULIETTI, A
    SERRETTI, R
    PERONI, M
    CERVINI, C
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 170 - 170
  • [9] Potential of Piperazinylalkylester Prodrugs of 6-Methoxy-2-Naphthylacetic Acid (6-MNA) for Percutaneous Drug Delivery
    Pawar, Vijay
    Thosani, Rushabh
    Kanhed, Ashish
    Giridhar, Rajani
    Yadav, Mange Ram
    AAPS PHARMSCITECH, 2015, 16 (03): : 518 - 527
  • [10] HPLC ASSAY OF 6-METHOXY-2-NAPHTHYLACETIC ACID, A MAJOR METABOLITE OF NABUMETONE, IN HUMAN SERUM
    JANG, EJ
    LEE, YJ
    PARK, MG
    SHIM, CK
    ANALYTICAL LETTERS, 1995, 28 (13) : 2379 - 2389
1234